medigraphic.com
ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2014, Number 5

<< Back Next >>

Salud Mental 2014; 37 (5)

Presencia de sintomatología ansiosa y depresiva en pacientes ambulatorios con patología neurológica

Ávila GLD, Duarte TH, Flores RLLJ, Ponce SS, Tong PJM

Language: Spanish
References: 48
Page: 399-406
PDF size: 276.24 Kb.


ABSTRACT

There is little information available describing psychiatric symptoms in non-psychiatric patients, with 25% of the patients being reported with such symptoms. These are most commonly observed with neurological disorders given the severity and degree of disability that they cause. The objective of this research was to identify the factors associated with the presence of anxiety and/or depression symptoms in patients with a neurological disorder. A transversal, descriptive study was carried out, taking 209 outpatients from the neurology service, with the aim of obtaining a period prevalence of the presence of anxiety and depression symptoms using the extended version of the Kessler Psychological Distress Scale (K10), and a sociodemographic interview to determine the association with factors that might influence on the presence and severity of such symptoms. All the participants signed an informed consent. We found scores superior to 21 points on the K10 scale (highly suggestive of the presence of an anxiety and/or depressive disorder) on 63.2% of the patients. These scores were more frequently found on patients with cerebrovascular diseases (85.7%), maintaining themselves above the 60% of the rest of the disorders. These results suggest a bigger association for more than half of the neurology outpatients to suffer from an anxiety and/or depressive symptoms severe enough to have benefits from an integral approach, with a bigger association in relation with more severe or incapacitating disorders, also the association was bigger on women. Thus, we need further research to determine the components of this association and identify effective interventions aiming to improve not just the patients’ health, but also their quality of life.


REFERENCES

  1. Maj M. “Psychiatric comorbidity”: An artifact of current diagnostic systems? Br J Psychiatry 2005;186:182-184.

  2. Starcevic V. Psychiatric comorbidity: Concepts, controversies and alternatives. Australas Psychiatry 2005;13(4):375-378.

  3. Kathol RG, Butler M, McAlpine DD, Kane RL. Barriers to physical and mental condition integrated service delivery. Psychosom Med 2010;72(6):511-518.

  4. Smith GC. From consultation-liaison psychiatry to integrated care for multiple and complex needs. Aus N Z J Psychiatry 2009;43(1):1-12.

  5. Pierce D, Wilson IG. Psychiatric comorbidity in general practice. Aust Fam Physician 2004;33(4):217-220.

  6. Lara M, Robles R, Orozco R, Real T et al. Estudio de costo-efectividad del tratamiento de la depresión en México. Salud Mental 2010;33(4):301-308.

  7. Corona R, Rojas CE, Alvarado S, Calderón FE et al. Prevalencia de síntomas de ansiedad y depresión en pacientes en aislamiento por trasplante de médula ósea. Gamo 2008;7(2):40-44.

  8. Fabián MG, García MC, Cobo C. Prevalencia de síntomas de ansiedad y depresión en pacientes con diabetes mellitus tipo 2 y su asociación con el tipo de tratamiento, complicaciones de la diabetes y comorbilidades. Med Int Mex 2010;26(2):100-108.

  9. Freire M, Rodríguez J, Möller I, Valcárcel A et al. Prevalencia de síntomas de ansiedad y depresión en pacientes con artritis psoriásica en consultas de reumatología. Reumatol Clin 2011;7(1):20-26.

  10. Ornelas RE, Tufiño MA, Sánchez JJ. Ansiedad y depresión en pacientes con cáncer de mama en radioterapia: Prevalencia y factores asociados. Acta Inv Psicol 2011;1(3):401.

  11. Fulop G. Anxiety disorders in the general hospital setting. Phychiatr Med 1990;8(3):187-195.

  12. Hansen MS, Fink P, Frydenberg M, Oxhøj M et al. Mental disorders among internal medical inpatients prevalence, detection, and treatment status. J Psychosom Res 2001;50(4):199-204.

  13. Zalta A. A meta-analysis of anxiety symptom prevention with cognitive- behavioral interventions. J Anxiety Dis 2011;25(5):749-760.

  14. Costello EJ, Egger HL, Angold A. The developmental epidemiology of anxiety disorders: phenomenology, prevalence, and comorbidity. Child Adolesc Psychiatr Clin N Am 2005;14(4):631–648.

  15. Boden JM, Fergusson DM, Horwood LJ. Anxiety disorders and suicidal behaviours in adolescence and young adulthood: findings from a longitudinal study. Psychol Med 2007;37(3):431–440.

  16. Dissanayaka NN, Sellbach A, Matheson S, O’Sullivan JD et al. Anxiety disorders in Parkinson’s disease: Prevalence and risk factors. Mov Disord 2010;25(7):838-845.

  17. Lyketsos CG, López O, Jones B, Fitzpatrick AL et al. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health study. JAMA 2002;288(12):1475- 1483.

  18. Ekinci O, Titus JB, Rodopman AA, Berkem M et al. Depression and anxiety in children and adolescents with epilepsy: Prevalence, risk factors, and treatment. 2009;14(1):8-18.

  19. Harden CL. The co-morbidity of depression and epilepsy: Epidemiology, etiology and treatment. Neurology 2002;59(6 Suppl 4):S48-555.

  20. Jackson M, Turkington D. Depression and anxiety in epilepsy. J Neurol Neurosurg Psychiatry 2005;76(Suppl 1):i45-147.

  21. Martínez-Pérez B, González-Goizueta E, Mauri-Llerda J. Depresión y epilepsia. Rev Neurol 2002;35(6):580-586.

  22. Teril L, Ferretti L, Gibbons L, Logsdon RG et al. Anxiety in Alzheimers’s disease: Prevalence and comorbidity. J Geront A Biol Sci Med Sci 1999;54(7):M348-352.

  23. Arnold SD, Forman LM, Brigidi BD, Carter KE et al. Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors. Neuro Oncol 2008;10(2):171-181.

  24. Devlen J. Anxiety and depression in migraine. J R Soc Med 1994;87(6): 338-341.

  25. Beekman AT, De Beurs E, van Balkom AJ, Deeq DJ et al. Anxiety and depression in later life: Co-occurrence and communality of risk factors. Am J Psychiatry 2000;157(1):89-95.

  26. Medina-Mora M, Borges G, Lara C, Benjet C et al. Prevalencia de trastornos mentales y uso de servicios: Resultados de la Encuesta Nacional de Epidemiología Psiquiátrica en México. Salud Menta 2003;26(4):1-16.

  27. Burcusa SL, Iacono WG. Risk for recurrence in depression. Clin Psych Review 2007;27:959–985.

  28. Carson AJ, Ringbauer B, MacKenzie L, Warlow C, et al. Neurological disease, emotional disorder, and disability: they are related: a study of 300 consecutive new referrals to a neurology outpatient department. J Neurol Neurosurg Psychiatry 2000;68(2):202–206.

  29. Hamilton J, Campos R, Creed F. Anxiety, depression and the management of medically unexplained symptoms in medical clinics. J R Coll Physicians Lond 1996;30(1):18-20.

  30. Wells KB, Stewart A, Hays RD, Burnam MA et al. The functioning and well-being of depressed patients. JAMA 1989;262(7):914–919.

  31. Kessler R, McGonagle K, Zhao S, Nelson C et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51(1):8-19.

  32. Kessler R, Ustun TB. The World Mental Health (WMH) survey initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J M Psych Research 2004;13(2):93-121.

  33. Vargas BE, Villamil V, Rodríguez C, Pérez J et al. Validación de la escala Kessler 10 (K10) en la detección de depresión y ansiedad en el primer nivel de atención. Propiedades psicométricas. Salud Mental 2011;34(4):323-331.

  34. Andrews G, Slade T. Interpreting scores on the Kessler Psychological Distress Scale (K10). Aus N Z J Public Health 2001;25(6):494-497.

  35. Baillie AJ. Predictive gender and education bias in Kessler´s psychological distress Scale (K10). Soc Psychiatry Psychiatr Epidemiol 2005;40(9):743-748.

  36. Australian Bureau of Statistics. Information paper: Use of the Kessler Psychological Distress Scale in ABS health surveys. Canberra, Australia: 2003; p. 14.

  37. Runkewitz K, Kirchmann H, Strauss B. Anxiety and depression in primary care patients: Predictors of symptom severity and developmental correlates. J Psychosom Res 2006;60(5):445-453.

  38. Frühwald S, Löffler H, Eher R, Saletu B et al. Relationship between depression, anxiety and quality of life: A study of stroke patients compared to chronic low back pain and myocardial ischemia patients. Psychopathology 2001;34(1):50-56.

  39. Beck AT, Rush AJ, Shaw BF, Emery G. The role of emotions in cognitive therapy. Ch. 2 in Cognitive therapy of depression. New York, NY: Guilford Press; 1979; p. 34-44.

  40. Wells A. Basic characteristics. Ch. 2 in Cognitive therapy of anxiety disorders: A practice manual and conceptual guide. Chichester: Wiley; 1997; p. 42-57.

  41. Riskind JH, Tzur D, Williams NL, Mann B et al. Short-term predictive effects of the looming cognitive style on anxiety disorder symptoms under restrictive methodological conditions. Behav Res Ther 2007;45(8):1765-1777.

  42. Obsessive Compulsive Cognitions Working Group. Cognitive assessment of obsessive–compulsive disorder. Behav Res Ther 1997;35(7):667-681.

  43. Gentes EL, Ruscio AM. A meta-analysis of the relation of intolerance of uncertainty to symptoms of generalized anxiety disorder, major depressive disorder, and obsessive–compulsive disorder. Clin Psychol Review 2011;31(6):923-933.

  44. Breslau N, Lipton RB, Stewart WF, Schultz LR et al. Comorbidity of migraine and depression: Investigating potential etiology and prognosis. Neurology 2003;60(8):1308-1312.

  45. Mongini F, Rota E, Deregibus A, Ferrero L et al. Accompanying symptoms and psychiatric comorbidity in migraine and tension-type headache patients. J Psychosom Res 2006;61(4):447-451.

  46. Beyenburg S, Mitchell AJ, Schmidt D, Elger CE et al. Anxiety in patients with epilepsy: Systematic review and suggestions for clinical management. Epilepsy Behav 2005;7(2):161-171.

  47. Johnson EK, Jones JE, Seidenberg M, Hermann BP. The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy. Epilepsia 2004;45(5):544:550.

  48. De Souza EA, Salgado PC. A psychosocial view of anxiety and depression in epilepsy. Epilepsy Behav 2006;8(1):232-238.




2020     |     www.medigraphic.com